Trials / Completed
CompletedNCT02101112
Bioavailability of Apixaban Crushed Tablet
Relative Bioavailability of Crushed Apixaban Tablets Administered With Water or Apple Sauce Compared With Intact Tablet in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 69 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether the bioavailability of apixaban crushed tablets suspended in water or mixed with applesauce is similar to the bioavailability of apixaban whole tablets administered orally.
Detailed description
This study will investigate the bioavailability of apixaban administered as crushed tablets suspended in water and as crushed tablets mixed with applesauce compared with that of whole tablets. The study results may allow enhancement of the apixaban label to include alternative methods of apixaban administration, which may be of benefit to patients who have difficulty swallowing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Apixaban |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2014-05-01
- Completion
- 2014-05-01
- First posted
- 2014-04-01
- Last updated
- 2016-03-03
- Results posted
- 2016-03-03
Source: ClinicalTrials.gov record NCT02101112. Inclusion in this directory is not an endorsement.